Videos
Episode 11
Biosimilars
UNPACKED
Biosimilar transition policies are paving the way for new, innovative arthritis treatments. Learn about biosimilar safety and efficacy and discover research that our scientists are doing to address patient concerns.
Episode 11
Webinar
RECORDING
Learn about biosimilars and biosimilar transition policies from Arthritis Research Canada’s Scientific Director, Dr. Diane Lacaille, and one of our patient partners who lives with rheumatoid arthritis in this Episode 11 webinar recording.
Educational grants-in-aid provided by:
